[HTML][HTML] The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming 8th …
H Asamura, K Chansky, J Crowley, P Goldstraw… - Journal of thoracic …, 2015 - Elsevier
Introduction Nodal status is considered to be one of the most reliable indicators of the
prognosis in patients with lung cancer and thus is indispensable in determining the optimal …
prognosis in patients with lung cancer and thus is indispensable in determining the optimal …
[HTML][HTML] The IASLC lung cancer staging project: proposals for the revision of the M descriptors in the forthcoming eighth edition of the TNM classification of lung cancer
WEE Eberhardt, A Mitchell, J Crowley, H Kondo… - Journal of thoracic …, 2015 - Elsevier
Introduction The aim of this study is to analyze all metastatic (M) categories of the current
tumor, node, and metastasis (TNM) classification of lung cancer with the objective of …
tumor, node, and metastasis (TNM) classification of lung cancer with the objective of …
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a …
JF Vansteenkiste, BC Cho, T Vanakesa… - The lancet …, 2016 - thelancet.com
Background Fewer than half of the patients with completely resected non-small-cell lung
cancer (NSCLC) are cured. Since the introduction of adjuvant chemotherapy in 2004, no …
cancer (NSCLC) are cured. Since the introduction of adjuvant chemotherapy in 2004, no …
Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international …
NK Altorki, X Wang, D Wigle, L Gu… - The Lancet …, 2018 - thelancet.com
Background Increased detection of small-sized, peripheral, non-small-cell lung cancer has
renewed interest in sublobar resection instead of lobectomy, the traditional standard of care …
renewed interest in sublobar resection instead of lobectomy, the traditional standard of care …
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
A D'incecco, M Andreozzi, V Ludovini, E Rossi… - British journal of …, 2015 - nature.com
Background: Agents targeting programmed death-1 receptor (PD-1) and its ligand (PD-L1)
are showing promising results in non-small-cell lung cancer (NSCLC). It is unknown whether …
are showing promising results in non-small-cell lung cancer (NSCLC). It is unknown whether …
Results of the randomized Danish lung cancer screening trial with focus on high-risk profiling
Rationale: As of April 2015, participants in the Danish Lung Cancer Screening Trial had
been followed for at least 5 years since their last screening. Objectives: Mortality, causes of …
been followed for at least 5 years since their last screening. Objectives: Mortality, causes of …
Management of non-small-cell lung cancer: recent developments
Non-small-cell lung cancer is one of the leading causes of deaths from cancer worldwide.
Therefore, improvements in diagnostics and treatments are urgently needed. In this review …
Therefore, improvements in diagnostics and treatments are urgently needed. In this review …
The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy
Stromal cells within the tumor microenvironment are essential for tumor progression and
metastasis. Surprisingly little is known about the factors that drive the transcriptional …
metastasis. Surprisingly little is known about the factors that drive the transcriptional …
Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice …
Objectives Stage III non-small cell lung cancer (NSCLC) describes a heterogeneous
population with disease presentation ranging from apparently resectable tumors with occult …
population with disease presentation ranging from apparently resectable tumors with occult …
A review of chemotherapy and photodynamic therapy for lung cancer treatment
A El-Hussein, SL Manoto… - Anti-Cancer Agents …, 2021 - ingentaconnect.com
Cancer is among the leading causes of mortality and morbidity worldwide. Among the
different types of cancers, lung cancer is considered to be the leading cause of death related …
different types of cancers, lung cancer is considered to be the leading cause of death related …